Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain
MEXICO CITY, May 6, 2025 /CNW/ – Apotex Inc. (referred to as 'Apotex' or 'the Company') today announced it has entered into an exclusive licensing agreement with Formosa Pharmaceuticals ('Formosa', 6838.TW), for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery, upon regulatory approval.
APP13007 was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the corticosteroid clobetasol propionate, and it is derived from Formosa Pharma's proprietary APNT® nanoparticle formulation platform. This novel formulation proved statistically and clinically superior to its matching placebo in Phase 3 trials in the United States (p<0.001).
This license agreement for the Mexican market adds to Apotex's existing exclusive rights to this product in Canada.
'At Apotex, we are committed to delivering access to medicines and health products, and unlocking new possibilities for patients through partnerships. We are pleased to bring access to APP13007 (clobetasol propionate ophthalmic suspension, 0.05%) to the Mexican market upon regulatory approval. Our agreement with Formosa Pharmaceuticals further demonstrates Apotex's leading position as partner of choice in the Americas for pharmaceutical licensing and product acquisitions as we continue to execute our Journey of Heath growth strategy,' said Alok Kanti, President, Apotex International.
'Having started our journey together in 2024, Formosa Pharma is pleased to expand the partnership with Apotex to include the Mexico territory,' said Erick Co, President and CEO of Formosa Pharmaceuticals. 'Our experience with Apotex's Canadian team underscored their commitment to branded and differentiated ophthalmology products, giving us full confidence that APP13007 will reach ophthalmologists and patients in Mexico as soon as possible.'
About Apotex Inc.
Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people worldwide, with a broad portfolio of generic, biosimilar, innovative branded pharmaceuticals and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. Learn more about us at www.apotex.com.
About Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc. (6838.TWO) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation technology (APNT®), through which APP13007 was developed, improves the dissolution and bioavailability of APIs for topical, oral, and inhaler administration. Resulting formulations have high uniformity, purity, and stability, thereby allowing the utilization of poorly soluble or extremely potent drug agents which otherwise may face insurmountable challenges in delivery and penetration to target tissues. For more details about Formosa Pharma and APNT®, visit www.formosapharma.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/apotex-announces-expansion-of-licensing-agreement-with-formosa-pharmaceuticals-to-mexico-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery-302447820.html
SOURCE Apotex Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 hours ago
- The Star
AirAsia close to buying at least 100 Airbus jets
AirAsia operates an all-Airbus fleet and has previously said it was looking to add smaller planes to its fleet for regional routes. PARIS: AirAsia is in advanced discussions to place an order for at least 100 Airbus jets at next week's Paris Airshow, a deal likely to mark the introduction to its fleet of the planemaker's smallest jet, the A220, industry sources say. Malaysia-based low-cost carrier AirAsia operates an all-Airbus fleet and has previously said it was looking to add smaller planes to its fleet for regional routes. One of Airbus's biggest customers with a few hundred planes already on order, the airline has not placed an order since before the pandemic. It has taken few deliveries in recent years and has been steadily restructuring its order book as it faced financial difficulties. The company, hard hit by pandemic travel restrictions, was classified by Malaysia's stock exchange as financially distressed in 2022. It says it hopes to exit this status by the middle of this year. Capital A plans to sell its AirAsia aviation business to long-haul unit AirAsia X to consolidate long and short-haul operations under a single AirAsia brand. — Reuters
The Star
8 hours ago
- The Star
Passengers reschedule travel plans and seek refunds following Jetstar Asia's abrupt closure
Jetstar Asia cancelled seven flights from Changi Airport on June 11 and re-timed another seven more. - Photo: ST SINGAPORE: Fin Guo was scheduled to fly home to Singapore from Okinawa at 9.20am on Wednesday (June 11), but the night before he was due to head to the airport, he was notified that his Jetstar Asia flight would be delayed by over 12 hours. Because of the delay, the 38-year-old will land in Singapore at 2.30am on June 12 – just hours before he's due at work at 9am. The budget carrier is the only airline that offers a direct flight between Okinawa and Singapore, so Mr Guo, who works in advertising, could only sit and wait. 'Now I'm typing this in Naha Airport,' he said to The Straits Times in a text message. 'I just want to fly back to Singapore tonight.' Guo was among thousands of passengers who were affected by flight delays or cancellations following the surprise announcement on June 11 that Jetstar Asia would cease operations from July 31. The airline cancelled seven flights from Changi Airport on June 11 and re-timed another seven more. Aside from disrupted travel plans, other affected passengers also told ST that they found it difficult to get refunds for flight bookings. In a June 11 statement, the Singapore-based airline announced that it would close, citing rising costs and growing regional competition. ST understands that Jetstar Asia had decided to suspend flights at Changi Airport on the morning of June 11, so its crew would not receive the news of the airline's closure while in the air. Heather Cher had her family's flight to Penang on June 11 delayed by eight hours, from 7.25am to 3.25pm. 'We lost a day, because we'll reach only at the end of the day. It's a waste of time,' she said. The 50-year-old said she was disappointed by Jetstar's closure. She frequently takes the airline to Penang to visit relatives. Gary Cheong said he and his family woke up at 5am on June 11 to leave for the airport, not knowing that their flight had been re-timed. He had missed the e-mail Jetstar sent on June 10 that their flight to Penang had been re-timed. 'They should have let us know through SMS since it's urgent,' said the 58-year-old, who works as an assistant manager. Jetstar Asia's closure will mean one less option for Cheong and his family, who travel to Penang at least four times a year. The airline's closure came as a surprise to many passengers, including Ms Hayley P and her husband. They had booked a direct flight to Labuan Bajo on July 27. The route was recently released by the carrier. On June 11, they were informed that the flight has since been cancelled, and they would receive a refund within seven days. 'I'm hoping they follow through with an easy process and people don't need to chase,' she said. The 42-year-old floral stylist will now have to make a longer trip, since she has to fly through Bali, which will mean additional flights and two nights of accommodation. The changes come at a significant expense, she said. Some other passengers such as Charlotte Tan, 38, are worried that they will have difficulty getting refunds. Tan has over S$500 in travel vouchers with the airline from a flight cancellation in 2023 and said she was concerned about getting her money back. 'I just hope that there is some clarity soon,' she said. Consumers Association of Singapore (Case) president Melvin Yong urged passengers to approach the consumer watchdog if they require assistance. 'Case is working with Jetstar Asia to clarify how it intends to handle and process these refunds and rescheduled flights, and the recourse available to consumers should there be a dispute,' Yong wrote on Facebook. - The Straits Times/ANN
The Sun
11 hours ago
- The Sun
Nvidia trumpets European AI infrastructure push
PARIS: US chip giant Nvidia on Wednesday announced a broad infrastructure push into Europe, partnering with local companies to help build the continent's 'own ecosystem' for AI, chief executive Jensen Huang said in Paris. 'In just two years we will increase the amount of AI computing capacity in Europe by a factor of 10,' Huang told attendees at the French capital's annual Vivatech trade fair, striding around the stage wearing his trademark leather jacket. California-based Nvidia is by far the largest producer of chips for AI -- notably the Graphics Processing Units (GPUs) originally developed for high-end gaming. Nvidia's chips have proved uniquely suited for generative AI, whether powering robots, software or self-driving cars. Singling out a local firm, Huang said Nvidia would partner with French AI startup Mistral to build a cloud platform powered by 18,000 of Nvidia's latest high-end Blackwell chips. Basing the billions of euros (dollars) worth of hardware in Europe would offer firms the 'strategic autonomy they need', Mistral chief Arthur Mensch told AFP, adding that the project would 'strengthen European technological leadership'. Huang said that Nvidia would build up existing partnerships, such as with French electrical goods maker Schneider Electric, including on developing gigantic data centres dedicated to AI -- which Nvidia calls 'AI factories'. It will also strengthen work with Germany's Siemens on so-called 'digital twins' simluating real-world environments, and on automating industrial processes. Nvidia plans to feed its chips into data centres across Europe, including in Spain, Italy, Britain, Finland, Germany and Sweden. The world's government chiefs 'all want to have AI factories, they all want AI to be part of their infrastructure,' Huang said. He added that Nvidia was partnering with major companies to develop their own AI models more easily, such as French banking giant BNP or cosmetics heavyweight L'Oreal. 'I'm so happy that Europe is going all-in on AI,' he said. Europe is well behind competitors like the United States and China in building up the computing power needed to power generative artificial intelligence. The continent hosts 'less than five percent of global computing power, whereas we consume 20 percent,' French President Emmanuel Macron's office said in a press briefing ahead of the leader's visit to Vivatech. With its ability to sell into China still crimped by American export restrictions, Nvidia is on the hunt for growth opportunities elsewhere around the world.
